首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1560813

全球疝氣修補設備市場 - 2024 - 2031

Global Hernia Repair Devices Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年，全球疝氣修補設備市場規模達47億美元，預計2031年將達到115億美元，2024-2031年預測期間複合年成長率為8.7%。

疝氣修補裝置是用於疝氣手術治療的醫療工具，疝氣是器官或組織從肌肉或組織壁的薄弱點突出的情況。這些裝置，例如網片、縫線、大頭釘和補片，可以加強薄弱區域並防止復發。網狀物通常由合成或生物材料製成，提供結構支撐並促進組織整合。縫合線和大頭釘在手術過程中固定網片。疝氣修復裝置在開放式和微創手術中都至關重要，可透過減少疝氣復發和術後併發症來恢復正常解剖結構並改善患者預後。

市場動態：

驅動程式和限制

設備進步的提高

疝氣修復設備的最新進展顯著改善了手術效果，縮短了恢復時間，並將併發症的風險降至最低。

腹腔鏡和機器人輔助手術技術的進步使得網片放置更加精確，切口更小，減少了術後疼痛並加快了恢復時間。 3D 成像和擴增實境提高了疝氣修復的準確性。固定裝置的創新，例如自固定網，可以減少組織損傷和術後疼痛。這些進步，加上組織工程和再生醫學方面正在進行的研究，正在為更有效、侵入性更小的疝氣修復方案鋪平道路，從而實現更好的長期結果並提高患者的舒適度。

與設備相關的併發症

由於疼痛、感染、復發、沾黏、腸阻塞和器官穿孔等不良反應，疝氣修補裝置市場面臨挑戰。英國外科雜誌報告一週後沾黏減少，但一個月後沾黏沒有預防。 FDA 報告稱，召回的網片會導致腸道預成形和阻塞，而 Ethicon Physio 網片植入物的遷移會導致過度疼痛和嚴重損傷。

細分市場分析

全球疝氣修復設備市場根據產品類型、疝氣類型、最終用戶和地區進行細分。

產品類型細分市場的網片和補片約佔疝氣修補器市場佔有率的 41.3%

從產品類型來看，Mesh & patch 佔約 41.3%。網片和補片在疝氣修復手術中至關重要，可為薄弱或受損的組織提供額外的支撐並加強腹壁。網狀物通常由聚丙烯或聚酯等合成材料製成，放置在薄弱區域的上方或下方，以分散腹壁上的機械應力並支持癒合過程。補片是一種較小的扁平片，用於不太廣泛的修復或小疝氣，通常用於腹腔鏡手術。它們固定在缺損處，加固組織並防止內臟突出。

市場地域佔有率

預計北美在整個預測期內將佔據總市場佔有率的 38.4% 左右

由於疝氣盛行率的上升、新產品的推出、FDA 的批准以及與其他公司的擴張，預計北美在整個預測期內將佔據約 38.4% 的市場佔有率。此外，成長可歸因於發達的醫療基礎設施、醫療保健支出的增加以及對微創手術的認知的提高。

例如，根據醫療保健成本和利用項目資料以及美國食品和藥物管理局的全球數據，美國每年估計進行611,000 例腹側疝修補術和100 萬例腹股溝疝氣修補術，這些手術估計每年超過2000 萬例，使得疝氣修補是世界上最常進行的一般外科手術之一。

Hernia repair devices are medical tools used in the surgical treatment of hernias, where an organ or tissue protrudes through a weak spot in the muscle or tissue wall. These devices, such as meshes, sutures, tacks, and patches, reinforce the weakened area and prevent recurrence. Meshes, typically made from synthetic or biological materials, provide structural support and promote tissue integration. Sutures and tacks secure the mesh during surgery. Hernia repair devices are crucial in both open and minimally invasive procedures, restoring normal anatomy and improving patient outcomes by reducing hernia recurrence and postoperative complications.

Market Dynamics: Drivers & Restraints

Rise in advancements of devices

Recent advancements in hernia repair devices have significantly improved surgical outcomes, reduced recovery times, and minimized the risk of complications.

Advancements in laparoscopic and robotic-assisted surgical techniques have led to more precise mesh placement with smaller incisions, reducing post-operative pain and speeding up recovery times. 3D imaging and augmented reality have improved the accuracy of hernia repairs. Innovations in fixation devices, like self-fixating meshes, reduce tissue damage and postoperative pain. These advancements, combined with ongoing research in tissue engineering and regenerative medicine, are paving the way for more effective, less invasive hernia repair options with better long-term outcomes and enhanced patient comfort.

Complications associated with the devices

The market for hernia repair devices faces challenges due to adverse effects such as pain, infection, recurrence, adhesion, bowel obstruction, and organ perforation. The British Journal of Surgery reports reduced adhesion for a week, but no adhesion prevention after a month. The FDA reports recalled mesh leading to bowel preformation and obstruction, and Ethicon physio mesh implant migration causing excessive pain and severe damage.

Market Segment Analysis

The global hernia repair devices market is segmented based on product type, hernia type, end user, and region.

The mesh & patch from the product type segment accounted for approximately 41.3% of the hernia repair devices market share

The mesh & patch from the product type segment accounted for approximately 41.3%. Mesh and patches are essential in hernia repair surgeries, providing additional support to weakened or damaged tissue and reinforcing the abdominal wall. Meshes, typically made from synthetic materials like polypropylene or polyester, are placed over or under the weakened area to distribute mechanical stress across the abdominal wall and support the healing process. Patches, smaller, flat pieces used for less extensive repairs or small hernias, are typically employed in laparoscopic procedures. They are fixed over the defect, reinforcing the tissue and preventing the protrusion of internal organs.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to rise in the prevalence of hernia, novel product launches, FDA approvals, and expansion with other companies. Also, growth can be attributed to developed healthcare infrastructure, greater expenditure on healthcare, and higher awareness about minimally invasive surgeries.

For instance, an estimated 611,000 ventral and 1 million inguinal hernia repairs are performed each year in the US, according to Healthcare Cost and Utilization Project data and the US Food and Drug Administration globally, these surgeries are estimated to top 20 million a year, making hernia repair one of the most commonly performed general surgery procedures in the world.

Market Segmentation

By Product Type

Mesh & Patch

Endoscopy Instruments

Surgical Instruments

Others

By Hernia Type

Inguinal hernia

Hiatal hernia

Umbilical hernia

Incisional hernia

Femoral Hernia

Spigelian Hernia

Flank/Lumbar Hernia

Epigastric Hernia

By End User

Hospitals

Clinics

Ambulatory Surgical Centers

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Medtronic Plc, B. Braun Melsungen AG, Cook Inc., C.R. Bard, Integra Lifesciences Holdings Corporation, Baxter International Inc., Cooper Surgical Inc., Lifecell Corporation, Stryker Corporation, Atrium Medical Corporation among others.

Key Developments

In April 2024, TELA Bio, Inc., a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, stated the U.S. launch of OviTex IHR (Inguinal Hernia Repair) Reinforced Tissue Matrix, specifically designed for use in laparoscopic and robotic-assisted inguinal hernia repair.

Why Purchase the Report?

To visualize the global hernia repair devices market segmentation based on product type, hernia type, end user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the hernia repair devices market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global hernia repair devices market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Hernia Type
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in advancements of devices
  - 4.1.1.2. Rise in the prevalence of hernias
- 4.1.2. Restraints
  - 4.1.2.1. Complications associated with the devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Mesh & Patch*
- 6.2.1. Introduction
6.3. Endoscopy Instruments
6.4. Surgical Instruments
6.5. Others

7. By Hernia Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
7.2. Market Attractiveness Index, By Hernia Type
7.3. Inguinal hernia*
- 7.3.1. Introduction
- 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4. Hiatal hernia
7.5. Umbilical hernia
7.6. Incisional hernia
7.7. Femoral Hernia
7.8. Spigelian Hernia
7.9. Flank/Lumbar Hernia
7.10. Epigastric Hernia

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Ambulatory Surgical Centers
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Medtronic Plc *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. B. Braun Melsungen AG
11.3. Cook Inc.
11.4. C.R. Bard
11.5. Integra Lifesciences Holdings Corporation
11.6. Baxter International Inc.
11.7. Cooper Surgical Inc.
11.8. Lifecell Corporation
11.9. Stryker Corporation
11.10. Atrium Medical Corporation (*LIST NOT EXHAUSTIVE)